Morning Briefing
Summaries of health policy coverage from major news organizations
Senate Panel Stops NSF Nominee From Advancing Amid Concerns Over Scientific Integrity
The New York Times: Senator Bill Cassidy Blocks Trump Pick To Head Science Agency
The chairman of the Senate health committee on Wednesday blocked President Trump’s nominee to lead the National Science Foundation, prolonging a leadership vacuum at an agency that has been rocked by the administration’s efforts to reshape research funding. The committee was scheduled to vote Wednesday on the nomination of Jim O’Neill, a science and technology investor who served briefly as a top deputy to Health Secretary Robert F. Kennedy Jr. and had been tapped months ago to lead the science agency. (Sella and Stolberg, 11/18)
Stat: FDA Turmoil: 7 Burning Questions After Heidi Overton Pulled
The White House pulled its nomination of Heidi Overton for commissioner of the Food and Drug Administration on Tuesday evening, startling senators on the health committee and introducing new questions about the future of the FDA. (Manto, 11/18)
On the immigration crisis —
Fierce Healthcare: DOL Moves To End Expedited Green Cards For Nurses, PTs
The U.S. Department of Labor proposed new policy this week that would end fast-track green cards for healthcare professionals like nurses and physical therapists—the latest in a string of policies from the Trump administration raising the bar for foreign-born workers and students across healthcare and other industries. Currently, nurses, physical therapists and other workers “with exceptional ability in the sciences or arts” are granted an exemption from an administrative test in the permanent labor certification program (PERM), a months-long administrative process in which an employer must prove there are no able, willing, qualified and available U.S. workers for a permanent job ahead of sponsoring a foreign worker. (Muoio, 11/18)
On MAHA —
Stat: Influential Preventive Services Panel To Meet For First Time In More Than A Year
A little-known but influential panel that recommends which preventive services must be covered by insurance will meet this week for the first time in more than a year, with a membership overhauled by health secretary Robert F. Kennedy Jr. (Cirruzzo, 11/18)
Stat: Before Midterm Losses, MAHA Spent On Itself Instead Of Candidates
When Tony Lyons, leader of the largest Make America Healthy Again organizations in Washington, spoke to supporters the day after the election, he was sullen. (Payne, Cueto and Cirruzzo, 11/19)
More news from the Trump administration —
Politico: NIH Asks If Fauci Secretly Wrote Paper That Dismissed Covid Lab Leak Theory
National Institutes of Health leaders may have been more involved in the influential March 2020 paper that sought to end debate about Covid’s origins than they’ve let on, according to Jay Bhattacharya, the lockdown critic who succeeded them atop the government’s health research agency. The paper attributed to five leading virologists, but not then-top NIH officials Anthony Fauci and Francis Collins, led news organizations and public health experts to dismiss evidence that pointed to a lab leak. (Chu, Paun and Röhn, 11/18)
The New York Times: N.I.H. Will Move Final Group Of Retired Research Chimps To Sanctuary
The last federally owned chimpanzees still living at an American research facility will begin moving to a sanctuary next year, the National Institutes of Health announced on Wednesday. As of Oct. 1, 34 chimps remained at the Keeling Center for Comparative Medicine and Research in Bastrop, Texas. They will move to Chimp Haven, a 200-acre sanctuary in Keithville, La., which serves as the official retirement home for government-owned chimpanzees. (Anthes, 11/18)
NPR: White House Fails To Credit Biden Role In U.S. Drug Deaths Drop
When the White House announced big improvements in the number of people dying from fatal drug overdoses earlier this week, officials pointed to hopeful new data from the Centers for Disease Control and Prevention showing U.S. drug deaths have plunged to their lowest level in roughly a decade, saving nearly 50,000 lives each year. But leading drug policy researchers say the White House statement also made misleading claims about the timing and cause of the remarkable public health success when it said that gains occurred primarily over the last 18 months due to policies enacted under President Trump's leadership. (Mann, 11/18)